Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma

Background To evaluate the value of locoregional radiation therapy (LRRT) in de novo metastatic nasopharyngeal carcinoma (mNPC) and identify suitable candidates for additional LRRT after palliative chemotherapy (PCT). Methods Patients with de novo mNPC received platinum‐based chemotherapy for a mini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Head & neck 2021-09, Vol.43 (9), p.2602-2610
Hauptverfasser:	Xu, Hanchuan, Lu, Lihu, Lu, Tianzhu, Xu, Yun, Zong, Jingfeng, Huang, Chaobin, Lin, Fengjie, Zheng, Yahan, Lin, Cheng, Lin, Senan, Qiu, Sufang, Pan, Jianji, Lin, Shaojun, Guo, Qiaojuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy de novo metastatic nasopharyngeal carcinoma Immunotherapy locoregional radiation therapy Metastases Metastasis Nasopharyngeal carcinoma oligometastatic disease palliative chemotherapy Patients polymetastatic disease Radiation therapy Throat cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background To evaluate the value of locoregional radiation therapy (LRRT) in de novo metastatic nasopharyngeal carcinoma (mNPC) and identify suitable candidates for additional LRRT after palliative chemotherapy (PCT). Methods Patients with de novo mNPC received platinum‐based chemotherapy for a minimum of four cycles with or without definitive LRRT via intensity‐modulated radiation therapy (IMRT) were all candidates for this study. Results A total of 168 patients were included for this analysis. Additional LRRT was associated with significantly longer median OS (69.5 vs. 17.8 months, p
ISSN:	1043-3074 1097-0347
DOI:	10.1002/hed.26726